The biotech firm, based in Blacksburg, Virginia, operates from the Virginia Tech Corporate Research Center and licenses patents from Virginia Tech. Their laboratory is equipped for the development, manufacture, and commercialization of biopolymers for research, therapeutics, energy, and sustainability. Techulon also develops drugs for treating infectious diseases, using novel peptide-peptide nucleic acids antimicrobial compounds to reveal DNA sequences in genes essential for microbe survival, thereby improving patient care.